Literature DB >> 7840354

Brain potential evidence for an auditory sensory memory deficit in schizophrenia.

S V Catts1, A M Shelley, P B Ward, B Liebert, N McConaghy, S Andrews, P T Michie.   

Abstract

OBJECTIVE: The multiple disorders of selective attention found in schizophrenia could be secondary to disturbances in sensory processing. The authors investigated this possibility by using an event-related potential index of auditory sensory memory, called "mismatch negativity."
METHOD: Medicated (N = 11) and neuroleptic-free (N = 11) patients with schizophrenia and patients with bipolar affective disorder (N = 11) were compared with age- and sex-matched healthy comparison subjects. Auditory stimuli were presented while the subjects were distracted with an attention-demanding visual task. Event-related potentials were elicited by infrequently occurring auditory stimuli (deviants) and by regularly presented auditory stimuli (standards), which differed slightly in duration. The difference in amplitude between the event-related potentials elicited by the deviant and standard stimuli was the mismatch negativity.
RESULTS: The amplitude of the mismatch negativity was significantly lower in both groups of schizophrenic patients than in the healthy comparison subjects. Mismatch negativity amplitude was significantly correlated with ratings of negative schizophrenic symptoms but not with positive symptoms. Compared with the matched comparison subjects, the bipolar affective disorder patients did not show lower amplitude of mismatch negativity. There was a significant negative correlation between age and mismatch negativity amplitude.
CONCLUSIONS: The abnormal auditory sensory memory processing indicated by low mismatch negativity amplitude in the schizophrenic patients cannot be accounted for by neuroleptic medication status. Because this abnormality was significantly related to measures of negative symptoms only, it may be a chronicity marker or reflect a predisposition to the development to schizophrenia. These findings implicate the auditory cortex in the pathophysiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840354     DOI: 10.1176/ajp.152.2.213

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  70 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

2.  Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge.

Authors:  I Grzella; B W Müller; R D Oades; S Bender; U Schall; D Zerbin; J Wolstein; G Sartory
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

3.  Electroencephalography (EEG) and event-related potentials (ERPs) with human participants.

Authors:  Gregory A Light; Lisa E Williams; Falk Minow; Joyce Sprock; Anthony Rissling; Richard Sharp; Neal R Swerdlow; David L Braff
Journal:  Curr Protoc Neurosci       Date:  2010-07

Review 4.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

5.  Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.

Authors:  P E Rasser; U Schall; J Todd; P T Michie; P B Ward; P Johnston; K Helmbold; V Case; A Søyland; P A Tooney; P M Thompson
Journal:  Schizophr Bull       Date:  2009-06-26       Impact factor: 9.306

6.  Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.

Authors:  D C Javitt; M Steinschneider; C E Schroeder; J C Arezzo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

Review 8.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

9.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants.

Authors:  Sumie Leung; Rodney J Croft; Valérie Guille; Kirsty Scholes; Barry V O'Neill; K Luan Phan; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

10.  Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.

Authors:  Sumie Leung; Rodney J Croft; Barry V O'Neill; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.